Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Depo-provera |
|
|
Clinical Trial: A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients with Osteoarthritis of the Hip.
This study is no longer recruiting patients.
|
Purpose
This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.
| Condition | Intervention | Phase |
|---|---|---|
| osteoarthritis of the hip musculoskeletal | Device: Synvisc (hylan G-F 20) | Phase III |
MedlinePlus related topics: Osteoarthritis
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Primary Outcomes: Pain relief
Study start: November 2003; Study completion: September 2006
Last follow-up: April 2006; Data entry closure: June 2006
Eligibility
Ages Eligible for Study: 35 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- patients with symptomatic osteoarthritis pain of hip
Exclusion Criteria:
- patients with current or prior conditions or treatment that would impede measurement of efficacy and safety
Location Information
Alabama
Sports Medicine, Huntsville, Alabama, 35802, United States
Alabama Clinical Therapeutics, Birmingham, Alabama, 35235, United States
Arizona
Affiliated Orthopedic Specialists, Scottsdale, Arizona, 85260, United States
Arkansas
Arkansas Orthopaedic Specialists, Little Rock, Arkansas, 72205, United States
California
Sharp Healthcare, San Diego, California, 92123, United States
Jackson Arthritis Center, Oakland, California, 94609, United States
Kerlan Jobe Orthopedic Clinic, Los Angeles, California, 90045, United States
Florida
Orthopedic Institute at Mercy Hospital, Miami, Florida, 33133, United States
Orthopedic Specialists, Clearwater, Florida, 33756, United States
Idaho
Idaho Arthritis & Osteoporosis Center, Meridian, Idaho, 83642, United States
Illinois
Illinois Bone and Joint Institute, Ltd., Morton Grove, Illinois, 60053, United States
Northwestern Orthopaedic Institute, Chicago, Illinois, 60611, United States
Iowa
Physician''''s Clinic of Iowa, Cedar Rapids, Iowa, 52401-2152, United States
Kansas
Kansas City Orthopedic Group, Leawood, Kansas, 66211, United States
Kentucky
Bluegrass Orthopaedics, Lexington, Kentucky, 40509, United States
Louisiana
Special Surgery Center, Shreveport, Louisiana, 71109, United States
Maryland
Johns Hopkins University, Baltimore, Maryland, 21239, United States
Michigan
Family Orthopedic Associates, Flint, Michigan, 48507, United States
New Jersey
UMDNJ-RWJ University Orthopedic Group, New Brunswick, New Jersey, 08901, United States
New York
Hospital for Special Surgery, New York, New York, 10021, United States
Ohio
Hughston Sports Medicine Foundation, Columbus, Ohio, 31909, United States
Oklahoma
Health Research Institute, Oklahoma City, Oklahoma, 73109, United States
Oregon
Orthopedic Ctr for Joint Replacement & Sports Medicine, Grants Pass, Oregon, 97527, United States
Pennsylvania
Altoona Center for Clinical Research, Duncansville, Pennsylvania, 16635, United States
Allegheny Orthopedic Associates, Pittsburgh, Pennsylvania, 15212, United States
Lancaster Orthopedic Group, Lancaster, Pennsylvania, 17601, United States
South Carolina
Conway Medical Center, Conway, South Carolina, 29526, United States
Tennessee
Chattanooga Center for Sports, Chattanooga, Tennessee, 37404, United States
Texas
Private Practice, Lubbock, Texas, 79410, United States
Virginia
Lewis Gale Clinic, Inc., Salem, Virginia, 24153, United States
Washington
Arthritis Northwest, Seattle, Washington, 98166-2967, United States
Study chairs or principal investigators
David Perkins, Study Director, Genzyme
More Information
Study ID Numbers: SYNV-004-02
Last Updated: August 17, 2005
Record first received: August 17, 2005
ClinicalTrials.gov Identifier: NCT00131326
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: August 17, 2005
Record first received: August 17, 2005
ClinicalTrials.gov Identifier: NCT00131326
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- ¿Que Tipo de Control de La Natalidad Es Mejor Para Usted? (Office for Protection from Research Risks, OD, NIH, HHS)
- Birth Control Guide (Office of Consumer Affairs, OEA, FDA,)
email this page
print this page
bookmark this page
feedback on this page
